LEVELS OF VANCOMYCIN IN AQUEOUS-HUMOR AFTER TOPICAL EYE DROPS ADMINISTRATION

被引:16
作者
HUERVA, V
SINUES, B
DELBUEY, MA
CRISTOBAL, JA
MINGUEZ, E
LANUZA, J
PALOMAR, A
机构
[1] Department of Ophthalmology, University Clinic Hospital, Zaragoza
[2] Department of Pharmacology, School of Medicine, Zaragoza
来源
JOURNAL OF OCULAR PHARMACOLOGY | 1993年 / 9卷 / 02期
关键词
D O I
10.1089/jop.1993.9.167
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Vancomycin is an antibiotic which is especially active against Gram positive bacteria. At present, numerous infections of the anterior segment of the eye are caused by the Staphilococcus aureus and epidermis. Strains which are resitant to methicilin are more and more frequent and for this reason Vancomycin is becoming the antibiotic of choice to combat these infections since no resistance of the Staphilococcus to it has been demonstrated. The authors evaluated the levels of Vancomycin in aqueous humor after the administration of topical eye-drops. For the first two hours after the last administration, levels of 0.52 mug/ml were detected. These inhibit the growth of the majority of bacteria sensitive to Vancomycin. Between two and four hours, the levels decreased to 0.15 mug/ml; these are therapeutic levels for a large number of Gram positive bacteria. From four hours after the last administration, these levels are undetectable. Due to the success of its penetration, topical administration of Vancomycin should be considered as a therapeutic modality against infections by gram positive bacteria of the anterior segment. The ideal guideline for administration would be one drop every two hours, especially if the infection is severe. In this way, subconjunctival injection could be avoided.
引用
收藏
页码:167 / 170
页数:4
相关论文
共 12 条
[1]  
Sande M.A., Mandell G.L., Agentes antimicrobianos, pp. 1136-1137, (1986)
[2]  
Davis J.L., Koidou-Tsiligianni A., Plugfelder S.C., Miller D., Flynn H.W., Forster R.K., Coagulasa-negative Staphylococcal endphthalmitis. Increase in antimicrobial resistance, Ophthalmology, 95, pp. 1404-1410, (1988)
[3]  
Boldt H.C., Pulido J.S., Blodi C.F., Folk J.C., Weingeist T.A., Rural endophthalmitis, Ophthalmology., 96, pp. 1722-1726, (1989)
[4]  
Pryor J.C., Apt L., Leopold I.H., Intraocular penetration of vancomycin, Arch Ophthalmol., 67, pp. 92-95, (1962)
[5]  
Phinney R.B., Schwartz S.D., Lee D.A., Bandino B.J., Collagen shield delivery of gentamicin and vancomycin, Arch Ophthalmol., 106, pp. 1599-1604, (1988)
[6]  
Soriano F., Fernandez Roblas R., Aspectos actuales de las infecciones por estafilococos y corinebacterias, Medicine (Madr.)., 74, pp. 2897-2903, (1990)
[7]  
Montero J., Merchante M.M., Trueba A., Oyarzabal B., Estudio de la sensibilidad antibiótica del Estafilococo en nuestro medio, Arch Soc Esp Oftal., 58, pp. 357-363, (1990)
[8]  
Driebe W.T., Mandebaum S., Forster R.K., Et al., Pseudophakic endophthalmitis: diagnosis and management, Ophthalmology, 93, pp. 442-448, (1986)
[9]  
Affeldt J.C., Flynn H.W., Forster R.K., Et al., Microbial endophthalmitis resulting from ocular trauma, Ophthalmology, 94, pp. 407-413, (1987)
[10]  
Karchmer A.W., Archer G.L., Dismukes W.E., Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy, Ann Intern Med., 98, pp. 447-455, (1983)